AVEO Pharmaceuticals Inc
AVEO
Get informed when a big investor buys or sells
+ FollowMarket Cap$519.27M
Close$
$18.30
22% upside
Current Fair Value
22% upsideUndervalued by 22% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $519.27 Million |
|---|---|
| Enterprise Value | $480.55 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.78 |
| Beta | 0 |
| Outstanding Shares | 34,618,000 |
Return
| Return on Equity | -100.67% |
|---|---|
| Return on Assets | -28.69% |
| Return on Invested Capital | -41.65% |
Valuation & Multiples
| P/E Ratio | -8.43 |
|---|---|
| PEG | 12.3 |
| Price to Sales | 7.5 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.41 |
| Enterprise Value to EBIT | 1.58 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | -1 |
| Debt to Equity | 1.34 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About AVEO Pharmaceuticals Inc
CEO: Michael Bailey